Sign In
Buy NVAX
$10.20
-0.0100 (-0.0979%)
At Close: Jun 03, 2026
Novavax Appoints Charles Newton to Board of Directors
08:00am, Tuesday, 29'th Apr 2025
GAITHERSBURG, Md. , April 29, 2025 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced the appointment of Charles Newton to its board as an independent director.
FDA asks Novavax to complete new clinical trial for delayed COVID-19 shot, WSJ reports
03:35pm, Friday, 25'th Apr 2025
Federal regulators are asking Novavax to complete an additional clinical trial on its Covid-19 vaccine after previously delaying approval, the Wall Street Journal reported on Friday, citing people fam
FDA Asks Vaccine Maker to Complete New Clinical Trial for Delayed Covid-19 Shot
03:20pm, Friday, 25'th Apr 2025
A new randomized study could cost Novavax tens of millions of dollars, vaccine experts say.
Insight: As FDA delays Novavax' COVID vaccine approval, patients fight back
06:04am, Thursday, 24'th Apr 2025
Thousands of Americans campaigning for the Novavax COVID-19 booster got some good news this week: the FDA signaled it might still win approval after Health Secretary Robert F. Kennedy Jr cast doubt on
Novavax (NVAX) Surges 19.5%: Is This an Indication of Further Gains?
02:50am, Thursday, 24'th Apr 2025
Novavax (NVAX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the roa
Novavax's COVID-19 Vaccine Nears FDA Full Approval, Stock Jumps
05:00pm, Wednesday, 23'rd Apr 2025
Novavax, Inc. NAVX stock traded higher on Wednesday.
Novavax shares jump as FDA signals path to COVID vaccine approval
12:51pm, Wednesday, 23'rd Apr 2025
Novavax, Inc. (NASDAQ:NVAX) shares surged more than 16% after the company shared a positive update on its COVID-19 vaccine, which it believes is “approvable” based on its conversations with the U
Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know
10:06am, Wednesday, 23'rd Apr 2025
Novavax (NVAX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
FDA asks Novavax for commitment on post-approval studies for COVID vaccine
08:26am, Wednesday, 23'rd Apr 2025
Novavax said on Wednesday the U.S. Food and Drug Administration has sought a commitment from the COVID-19 vaccine maker for additional clinical data if it approves the shot.
Why the Market Dipped But Novavax (NVAX) Gained Today
06:50pm, Monday, 21'st Apr 2025
Novavax (NVAX) closed at $6.01 in the latest trading session, marking a +0.17% move from the prior day.
Here's Why Novavax (NVAX) Fell More Than Broader Market
06:50pm, Tuesday, 15'th Apr 2025
In the latest trading session, Novavax (NVAX) closed at $6.39, marking a -0.31% move from the previous day.
SHIELD-Utah Study Shows Novavax's COVID-19 Vaccine Induces Lower Reactogenicity Symptoms Compared to mRNA
07:00am, Tuesday, 15'th Apr 2025
Preliminary data showed Novavax's non-mRNA JN.1 COVID-19 vaccine induced lower frequency and severity of short-term side effects and impact on daily life compared with Pfizer-BioNTech mRNA vaccine Ful
NVAX Stock Tanks as HHS Secretary Raises Concern Over COVID-19 Jab
12:35pm, Friday, 11'th Apr 2025
The decline in Novavax stock follows the HHS Secretary's concerns regarding the efficacy of its protein-based COVID-19 vaccine in a recent interview.
Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know
10:05am, Friday, 11'th Apr 2025
Novavax (NVAX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Novavax shares tumble after U.S. health secretary raises concerns over COVID shot's efficacy
03:02pm, Thursday, 10'th Apr 2025
Vaccine maker Novavax's shares plunged over 22% on Thursday after Health and Human Services Secretary Robert F. Kennedy Jr. raised concerns about the company's COVID-19 vaccine in an interview with CB
